Ovitrelle 250mcg Pre-Filled Pen

Ovitrelle 250mcg pre-filled pen contains choriogonadotropin alfa (HCG), a hormone that mimics the action of luteinising hormone (LH) in the body. Clinicians prescribe this treatment for specific hormone-related conditions where HCG therapy is clinically appropriate. This is a prescription-only medicine, and you must complete a medical consultation before a registered clinician approves supply.

How This Treatment Works

Choriogonadotropin alfa binds to LH receptors and stimulates hormonal pathways involved in reproductive function. As a result, it supports natural processes that depend on luteinising hormone activity. Because it acts in a targeted way, clinicians use it within structured and carefully monitored treatment plans.

The pre-filled pen delivers a fixed 250 microgram dose via subcutaneous injection. Therefore, it allows accurate administration when used as instructed. Your clinician will explain how and when to administer the injection and will determine the appropriate schedule based on your individual treatment plan.

Who This Medicine Is For

This medicine is prescribed for patients whose clinician determines that HCG therapy is suitable based on medical history, examination findings and relevant blood tests. Suitability depends on individual assessment, and not all patients will be appropriate for treatment.

During your consultation, a clinician will review your overall health and treatment goals. Consequently, therapy remains personalised and clinically justified. Ongoing monitoring may be required depending on your indication and response to treatment.

Treatment Duration and Monitoring

The listed price is per pen. One device typically covers approximately 2–3 weeks, depending on the prescribed regimen. However, your clinician will determine the exact dosing frequency and duration of therapy.

Because hormone treatment requires supervision, you should attend all scheduled follow-up appointments and report any unexpected symptoms promptly. Always read the patient information leaflet carefully before starting treatment so you understand correct administration and safety advice.